Drug Shortage Report for APO-CANDESARTAN

Last updated on 2020-02-25 History
Report ID 3516
Drug Identification Number 02399105
Brand name APO-CANDESARTAN
Common or Proper name CANDESARTAN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) CANDESARTAN CILEXETIL
Strength(s) 32MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-20
Estimated end date 2020-02-28
Actual end date 2020-02-21
Shortage status Resolved
Updated date 2020-02-25
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2020-02-25 French Compare
v23 2020-02-25 English Compare
v22 2020-02-06 French Compare
v21 2020-02-06 English Compare
v20 2018-09-08 French Compare
v19 2018-09-08 English Compare
v18 2018-04-02 French Compare
v17 2018-04-02 English Compare
v16 2018-01-31 French Compare
v15 2018-01-31 English Compare
v14 2018-01-03 French Compare
v13 2018-01-03 English Compare
v12 2017-11-07 French Compare
v11 2017-11-07 English Compare
v10 2017-08-08 French Compare
v9 2017-08-08 English Compare
v8 2017-07-25 French Compare
v7 2017-07-25 French Compare
v6 2017-07-25 English Compare
v5 2017-05-25 French Compare

Showing 1 to 20 of 24